Adiponectin is Associated with Bone Mineral Density in Perimenopausal Women

Abstract

The aim of the current investigation was to investigate any potential effect of fasting plasma adiponectin concentration on bone tissue, and to find possible relationships of fasting plasma adiponectin level with different body composition, insulin sensitivity and physical performance parameters in a group of healthy perimenopausal women. Twenty-one premenopausal and 17 early postmenopausal women participated in this study. The women were matched for body mass index (BMI) and level of mean daily energy expenditure. Women had similar adiponectin (8.4 ± 3.9 vs. 9.9 ± 5.4 µg/ml) and leptin values (12.0 ± 7.7 vs. 14.0 ± 8.2 ng/ml) before and after menopause. Significant relationships were observed between plasma adiponectin and bone mineral content, total bone mineral density (BMD) and lumbar spine BMD values (r > - 0.36; p < 0.05). Furthermore, adiponectin had a significant negative association with total BMD (β = - 1.228; p = 0.004) and lumbar spine BMD (β = - 0.312; p = 0.005) independent of the influence that other measured body compositional, hormonal or physical performance factors may exert on BMD. Adiponectin was also significantly related to waist-to-hip ratio (WHR) (β = - 2.300; p = 0.002) and fasting insulin resistance index (FIRI) (β = - 0.006; p = 0.007) in separate regression models. No relationship was observed between leptin and measured bone, physical performance and insulin resistance values. Leptin significantly correlated to BMI (β = 0.018; p = 0.034), lean body mass (β = 0.025; p = 0.024) and fat mass (β = 0.019; p = 0.001) in separate regression models. In conclusion, the results of present study show that circulating adiponectin appears to exert an independent effect on BMD in perimenopausal women and may represent a link between adipose tissue and bone mineral density.

Adiponectin - Leptin - Bone mineral density - Adipose tissue - Perimenopausal women

References

• 1 Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women.  JAMA. 2003;  289 1799-1804
• 2 Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes.  Biochem Biophys Res Commun. 2002;  290 1084-1089
• 3 Brichard S M, Delporte M L, Lambert M. Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin.  Horm Metab Res. 2003;  35 337-342
• 4 Iwahashi H, Funabashi T, Kurokawa N, Sayama K, Fukuda E, Okita K, Imagawa A, Yamagata K, Shimomura I, Miyagawa J I, Matsuzawa Y. Plasma adiponectin levels in women with anorexia nervosa.  Horm Metab Res. 2003;  35 537-540
• 5 Scherer P E, Williams S, Fogliano M, Baldini G, Lodish H F. A novel serum protein similar to C1q, produced exclusively in adipocytes.  J Biol Chem. 1995;  270 26 746-26 749
• 6 Ferguson M A, White L J, McCoy S, Kim H W, Petty T, Wilsey J. Plasma adiponectin response to acute exercise in healthy subjects.  Eur J Appl Physiol. 2004;  91 324-329
• 7 Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley R E, Tataranni P A. Hypoadiponectemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia.  J Clin Endocrinol Metab. 2001;  86 1930-1935
• 8 Hulver M W, Saleh O, MacDonald K G, Pories W J, Barakat H A. Ethnic differences in adiponectin levels.  Metabolism. 2004;  53 1-3
• 9 Ryan A S, Berman D M, Nicklas B J, Sinha M, Gingerich R L, Meneilly G S, Egan J M, Elahi D. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity.  Diabetes Care. 2003;  26 2383-2388
• 10 Hotta K, Funahashi T, Arita Y, Takashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.  Arterioscler Thromb Vasc Biol. 2000;  20 1595-1599
• 11 Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S. Hypoadiponectemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus.  Metabolism. 2003;  52 1274-1278
• 12 Jürimäe T, Sudi K, Jürimäe J, Payerl D, Rüütel K. Relationships between plasma leptin levels and body composition parameters measured by different methods in postmenopausal women.  Am J Hum Biol. 2003;  15 628-636
• 13 Kanaley J A, Sames C, Swisher L, Swick A G, Ploutz-Snyder L L, Steppan C M, Sagendorf K S, Feiglin D, Jaynes E B, Meyer R T. Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age and menopausal status.  Metabolism. 2001;  50 976-982
• 14 Lenchik L, Register T C, Hsu F C, Lohman K, Nicklas B J, Freidman B I, Langefeld C D, Carr J J, Bowden D W. Adiponectin as a novel determinant of bone mineral density and visceral fat.  Bone. 2003;  33 646-651
• 15 Uusi-Rasi K, Kannus P, Cheng S, Sievanen H, Pasanen M, Heinonen A, Neunonen A, Hallun J, Feurst T, Genant H, Vuori I. Effect of alendronate and exercise on bone and physical performance of postmenopausal women: a randomized controlled trial.  Bone. 2003;  33 132-143
• 16 Lips P, Hesp R, Reeve J, Wootton R, Green J R, Klenerman L. High indices of remodelling in iliac trabecular bone predict reduced forearm cortical bone mass indices in patients with proximal femoral fractures.  Bone Miner. 1990;  11 93-100
• 17 Thong F S, McLean C, Graham T E. Plasma leptin in female athletes: relationship with body fat, reproductive, nutritional and endocrine factors.  J Appl Physiol. 2000;  88 2037-2044
• 18 Bouchard C, Tremblay A, Leblanc C, Lortie G, Savard R, Theriault G. A method to assess energy expenditure in children and adults.  Am J Clin Nutr. 1983;  37 461-467
• 19 World Health Organization .Measuring obesity - classification and description of anthropometric data. Eur/ICP/NUT 125-0612. V. Copenhagen: WHO Regional Office for Europe, 1988. 
• 20 Jürimäe T, Jürimäe J, Pihl E. Circulatory response to single circuit weight and walking training sessions of similar energy cost in middle-aged overweight females.  Clin Physiol. 2000;  20 143-149
• 21 Fernandez-Real J M, Vayreda M, Casamitjana R, Gonzalez-Huix F, Ricart W. The fat-free mass compartment influences serum leptin in men.  Eur J Endocrinol. 2000;  142 25-29
• 22 Hulver M W, Zheng D, Tanner C J, Houmard J A, Kraus W E, Slentz C A, Sinha M K, Pories W J, MacDonald K G, Dohm G L. Adiponectin is not altered with exercise training despite enhanced insulin action.  Am J Physiol Endocrinol Metab. 2002;  283 E861-E865
• 23 Berg A H, Combs T P, Du X, Brownlee M, Scherer P E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.  Nat Med. 2001;  7 947-953
• 24 Kontogianni M D, Dafni U G, Routsias J G, Skopuli F N. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women.  J Bone Miner Res. 2004;  19 546-554
• 25 Gavrila A, Chan J L, Yiannakouris N, Kontogianni M, Miller L C, Orlova C, Mantzoros C S. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by fasting or leptin administration in humans: cross-sectional and interventional studies.  J Clin Endocrinol Metab. 2003;  88 4823-4831
• 26 Hunter G R, Kekes-Szabo T, Treuth M S, Williams M J, Goran M, Pichon C. Intra-abdominal adipose tissue, physical activity and cardiovascular risk in pre- and post-menopausal women.  Int J Obes. 1996;  20 860-865
• 27 Morberg C M, Tetens I, Black E, Toubro S, Sorensen T I, Pedersen O, Astrup A. Leptin and bone mineral density: A cross-sectional study in obese and nonobese men.  J Clin Endocrinol Metab. 2003;  88 5795-5800
• 28 Thomas T, Burguera B. Is leptin the link between fat and bone mass.  J Bone Miner Res. 2002;  17 1563-1569
• 29 Berner H S, Lyngstadaas S P, Spahr A, Monjo M, Thommesen L, Drevon C A, Syversen U, Reseland J E. Adiponectin and its receptors are expressed in bone-forming cells.  Bone. 2004;  35 842-849
• 30 Motoshima H, Wu X, Sinha M K, Hardy V E, Rosato E L, Barbot D J, Rosato F E, Goldstein B J. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone.  J Clin Endocrinol Metab. 2002;  87 5662-5667
• 31 Faraj M, Havel P J, Phelis S, Blank D, Sneiderman A D, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects.  J Clin Endocrinol Metab. 2003;  88 1594-1602
• 32 Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y. Adipocyte-derived plasma protein, adiponectin, supresses lipid accumulation and class A scavanger receptor expression in human monocyte-derived macrophages.  Circulation. 2001;  103 1057-1063